Lincoln National Corp Viatris Inc Transaction History

Lincoln National Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$9.95 - $12.27 $1,860 - $2,294	-187 Reduced 1.77%	10,401 $109,000
Q1 2022 May 09, 2022	BUY	$9.81 - $15.4 $3,717 - $5,836	379 Added 3.71%	10,588 $115,000
Q4 2021 Jan 26, 2022	SELL	$12.09 - $14.68 $5,851 - $7,105	-484 Reduced 4.53%	10,209 $138,000
Q3 2021 Nov 05, 2021	SELL	$13.25 - $15.13 $14,773 - $16,869	-1,115 Reduced 9.44%	10,693 $145,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $2,632 - $3,278	-203 Reduced 1.69%	11,808 $169,000
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $24,366 - $33,242	-1,793 Reduced 12.99%	12,011 $168,000
Q4 2020 Feb 05, 2021	BUY	$14.3 - $18.74 $197,397 - $258,686	13,804 New	13,804 $259,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.